Eye-opening care. Life-changing results. Far-reaching implications.
At Chu Vision, we help patients move forward with confidence by providing clear, concise information upfront and kind, considerate care throughout. We are also committed to advancing the field of eye care. Learn more about how we have taken a leadership role within our professional community—locally and globally—to help bring leading-edge technologies to market.
Current Clinical Trials
+ Cataracts
Bausch & Lomb Viscoelastic for use in cataract Surgery
Cohesive viscoelastics are substances used to maintain space in the eye while a natural lens is removed and an intraocular lens is inserted during cataract surgery. This study compares the safety and effectiveness of a cohesive viscoelastic from Bausch & Lomb (CVisc50) to a control product from and Alcon (ProVisc)
Carl Zeiss Meditec MICOR
Current cataract extraction practice uses phacoemulsification, which is a high-energy ultrasound technology.
This study evaluates the clinical outcomes after use of low-energy micro-interventional irrigation/aspiration port (MICOR-304) to remove the lens prior to intraocular lens insertion in subjects undergoing routine cataract surgery.
+ Dry Eye
More information about these studies coming soon.
+ Fuchs' Dystrophy
Aerie Pharmaceuticals eye drop for Fuch’s Dystrophy
Fuchs' (pronounced fewks) Dystrophy causes fluid buildup in the cornea. This creates swelling and can lead to discomfort, glare, and blurred or cloudy vision.
This study will evaluate the reduction in the corneal swelling after use of the ey drop netarsudil, either once or twice daily, in patients diagnosed with Fuch's Dystophy.
Committed to Advancing the Field of Ophthalmology Through Research - Watch to learn more as we have participated in over 90 research studies!